Leukocyte telomere length and clinical characteristics in patients with type 2 diabetes mellitus with and without chronic kidney disease
The Ukrainian Biochemical Journal · 15.06.2026 · 98 (3) · 76-82
DOI: 10.15407/ubj98.03.076 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Ukrainian Biochemical Journal, online erschienen am 15.06.2026. Verfasst von Y. E. Rebrova und 3 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Telomeric mechanisms are considered important contributors to chronic kidney disease progression in patients with type 2 diabetes mellitus, although data on telomere length in diabetic kidney disease remain limited.
Objective
To evaluate the relationship between telomere length and clinical characteristics in patients with type 2 diabetes mellitus with and without chronic kidney disease.
Methods
The study included 100 patients with T2DM, divided into two groups: 50 with and 50 without CKD. Routine clinical and biochemical blood tests were performed for all subjects. Leukocyte telomere length was assessed by quantitative real-time polymerase chain reaction following the method described by Cawthon.
Results
T2DM patients with CKD were significantly older, had a longer duration of diabetes, exhibited significantly lower estimated glomerular filtration rate (eGFR), higher urine albumin-to-creatinine ratio and frequency of cardiovascular complications compared with non-CKD patients. No significant correlations were found between telomere length and age, eGFR, albuminuria, or cardiovascular disease in either group. In patients with type 2 diabetes mellitus chronic kidney disease was associated with higher frequency of pathologically short telomeres (20.8%) versus non-CKD patients (2.1%), suggesting accelerated cellular aging in CKD independent of chronological age.
Conclusions
Shortened telomeres in patients with type 2 diabetes mellitus and chronic kidney disease may reflect accelerated cellular aging and could serve as an additional marker for biological risk stratification beyond traditional renal indicators. Keywords: cellular aging, chronic kidney disease, telomeres, type 2 diabetes mellitus
Zitieren
APA
Rebrova, Y. E., Saienko, Y. A., Midlovets, K. K., & Mankovsky, B. M. (2026). Leukocyte telomere length and clinical characteristics in patients with type 2 diabetes mellitus with and without chronic kidney disease. The Ukrainian Biochemical Journal, 98(3), 76-82. https://doi.org/10.15407/ubj98.03.076
Vancouver
Rebrova YE, Saienko YA, Midlovets KK, Mankovsky BM. Leukocyte telomere length and clinical characteristics in patients with type 2 diabetes mellitus with and without chronic kidney disease. The Ukrainian Biochemical Journal. 2026;98(3):76-82. doi:10.15407/ubj98.03.076
BibTeX
@article{Rebrova2026,
author = {Rebrova, Y. E. and Saienko, Y. A. and Midlovets, K. K. and Mankovsky, B. M.},
title = {Leukocyte telomere length and clinical characteristics in patients with type 2 diabetes mellitus with and without chronic kidney disease},
journal = {The Ukrainian Biochemical Journal},
year = {2026},
volume = {98},
number = {3},
pages = {76--82},
doi = {10.15407/ubj98.03.076}
}
EUVIMED